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Objective. We aimed to assess the predictive value of the model of end-stage liver disease (MELD) in hospitalized cirrhotic patients
with and without spontaneous bacterial peritonitis (SBP) and fatal outcome. Methods. A cross-sectional study included 256
consecutive patients (199 men and 57 women) diagnosed with cirrhosis and ascites who were hospitalized at the University
Hospital Center in Tirana from January 2008 to December 2009. SBP was deﬁned as a neutrophil count of ≥250cells/mm3 in
ascitic ﬂuid. MELD score was based on laboratory parameters determined by UNOS Internet site MELD calculator. Results.I n
multivariable-adjusted logistic regression models controlling for age, sex, diabetes, and etiology, there was evidence of a positive
association of SBP with MELD score: the odds ratio (OR) for SBP for one unit increment of MELD score was 1.06 (95% Cl = 1.02–
1.09). MELD score was signiﬁcantly higher in fatal cases than nonfatal patients (mean age-adjusted score was 32.7 versus 18.4
overall; 34.8 versus 18.0 in SBP patients, and 32.0 versus 18.5 in non-SBP patients; all P<0.001). Conclusions. In this Albanian
sample of hospitalized cirrhotic patients, MELD score was conﬁrmed as a signiﬁcant predictor of both SBP and fatal outcome.
1.Introduction
Spontaneous bacterial peritonitis (SBP) is a common and
serious infection occurring in patients with cirrhosis and
ascites [1] which may be complicated by renal failure, sys-
temic sepsis, and poor survival [2, 3]. SBP originates due
to bacteria that translocate across the leaky gut [4, 5]. Un-
controlled bacterial growth in ascites ﬂuid then develops as a
result of an impaired host immune response [6, 7]. Numer-
ousstudiessuggestthat10–30% ofhospitalized patientswith
cirrhosis and ascites have SBP, with in-hospital mortality
ranging from 20–40% [8–10].
Outcome prediction of patients with chronic end-stage
liver disease (ESLD) is very important. In 2001, the Mayo
Clinic group suggested a novel model to predict the outcome
of patients with ESLD, which they named MELD [11, 12].
In 2003, MELD was formally adopted by the UNOS (United
Network of Organ Sharing) for allocation and quality con-
trol. It has since been validated in many other aspects of
terminal liver disease, including the prediction of prognosis
in viral or alcoholic hepatitis [13], risk of mortality among
cirrhotic patients [14], outcome following liver transplanta-
tion [15], and, recently, also as a prognostic tool for patients
w i t ha c u t el i v e rf a i l u r e[ 16].
Because of the signiﬁcant morbidity and mortality relat-
ed to SBP, identifying predisposing factors is of great interest.
MELD score is a measure of mortality risk in patients with
ESLD [17]. Development of ascites and encephalopathy, two2 Gastroenterology Research and Practice
complications of ESLD that are not used in the MELD
score calculation, has generally correlated with higher MELD
scores [18].
Because of low social economic level, poor sanitary con-
ditions, and lack of hepatitis B vaccination of the population
over 12-13 years old, the Albanian population is highly
infected with hepatitis B virus [19]. In our country we ﬁnd
also a high rate of alcohol abuse [20]. Due to these two
main factors, we have an important number of patients with
hepatic cirrhosis, SBP, and liver failure. We used MELD score
in our hospitalized patients with liver cirrhosis to predict the
occurrence of SBP and fatal outcome.
2. Methods
2.1. Study Population. Our cross-sectional study included
256 consecutive patients diagnosed with cirrhosis and ascites
hospitalized at the University Hospital Center in Tirana from
January 2008 to December 2009. We excluded patients with
(i) cirrhosis and ascitis who had antibiotic treatment or
upper gastrointestinal hemorrhage within two weeks prior
to admission; (ii) were on treatment with proton pump
inhibitors (PPI); (iii) patients with ascitis unrelated to their
cirrhosis such as congestive heart failure, malignancy with
metastasis; (iv) patients diagnosed with hepatocarcinoma in
the course of hospitalization.
2.2. Data Collection. Data collected included patient age,
sex, etiology of cirrhosis, history for diabetes mellitus, and
ascitic ﬂuid analysis. All patients underwent a diagnos-
tic paracentesis on admission. SBP diagnosis was based
on neutrophil count in ascitic ﬂuid ≥250cells/mm3.W e
did not require positive ascites ﬂuid cultures to diagnose
SBP. Patients with ascites ﬂuid neutrophil cell counts of
<250cells/mm3 were considered not to have SBP according
to the recommended guidelines of the European Association
for the Study of the Liver (http://www.easl.eu/). Paracentesis
was carried out with or without ultrasound guidance using a
standard sterile technique. All patients included in our study
were treated according to the recommended guidelines of
the European Association for the Study of the Liver. Labora-
tory data included total serum bilirubin, serum creatinine,
and prothrombin time with international normalized ratio
(INR). MELD score was based on laboratory parameters
(bilirubin, creatinine levels and INR) collected at admission
and determined by using the UNOS Internet site MELD
calculator (http://www.unos.org/).
2.3. Statistical Analysis. General linear model was used to
calculatemeanage-adjustedvaluesofMELDscore,bilirubin,
creatinine,andINRlevelsbySBPstatus.Age-adjustedbinary
logistic regression was used to assess the association of
SBP with sex, etiology, and case-fatality rate. Multivariable-
adjusted logistic regression was used to assess the inde-
pendent association of SBP with MELD score. Odds ratios
(OR), 95% conﬁdence intervals (CI), and P values (P)w e r e
calculated. The Statistical Package for Social Sciences (SPSS,
version 15.0, Chicago, Il, USA) was used for all the statistical
analysis.
3. Results
Our study included 256 patients (199 men and 57 women)
diagnosed with liver cirrhosis and ascites, of whom 64 (25%)
were complicated cases with SBP. The etiologic factors of
cirrhosis included alcoholic liver disease (n = 136, 53.1%),
viral hepatitis B (n = 76, 29.7%), viral hepatitis C virus
(n = 6, 2.3%), viral hepatitis with alcohol use (n = 12,
4.7%), and other etiologies (n = 26, 10.2%). Of 64 cases
with SBP, the etiology of cirrhosis was alcohol consumption
in36cases(56.3%),HBVinfectionin15cases(23.4%),HCV
infection in 5 cases (7.8%), alcohol + HBV in 1 case (1.6%),
and other etiologies in 7 cases (10.9%).
The characteristics of the two groups of patients, with
SBP and without SBP, are summarized in Table. There were
no signiﬁcant diﬀerences with regard to age (54.6 versus 54.2
years, P = 0.84), sex (men, 81.2% versus 82.8%, P = 0.88),
and diabetes mellitus (27.6% versus 31.3, P = 0.56) between
two groups. Alcohol-related etiology was the most common
causes of cirrhosis in both groups (52.1% versus 56.3%, P =
0.11). MELD score was signiﬁcantly higher in SBP patients
than non-SBP patients (age-adjusted mean score: 23.2 versus
19.5, P = 0.003). Conversely, there were no signiﬁcant
diﬀerences in mean levels of bilirubin, creatinine, and INR
(P = 0.37, P = 0.22 and P = 0.36, resp.). The prevalence
of SBP was signiﬁcantly higher among patients with a higher
MELD score (≥25): 37.5% versus 24.5%, P = 0.013.
In multivariable-adjusted logistic regression models con-
trollingforage,sex,diabetes,andetiology,therewasevidence
of a statistically signiﬁcant diﬀerence in SBP rates by MELD
score: the OR for developing SBP by each MELD point
was 1.06 (95% CI = 1.02–1.09, P = 0.002) (not shown in
Table 1).
Multivariable-adjusted logistic regression models were
run with introduction of bilirubin, creatinine, and INR lev-
els; there was no evidence of statistically signiﬁcant ﬁndings
(for bilirubin: OR = 1.01, 95% CI = 0.97–1.06, P = 0.483; for
creatinine: OR = 1.28, 95% CI = 0.71–2.29, P = 0.411; for
INR: OR = 0.92, 95% CI = 0.77–1.09, P = 0.326) (not shown
in Table 1).
The main causes of death among SBP patients were va-
riceal bleeding and hepatorenal syndrome (27% each), liver
failure(20%),hepatopulmonarysyndrome(13%),andother
causes of death (13%). Conversely, the main causes of
deathamongnon-SBPpatientswerevaricealbleeding(30%),
liverfailure(22%),hepatorenalsyndrome(10%),hepatopul-
monary syndrome (5%), and other causes of death (33%).
Case-fatality rate was signiﬁcantly higher in SBP patients
than non-SBP patients (23.4% versus 12.0%, P = 0.024).
MELD score was signiﬁcantly higher in fatal cases versus
nonfatal patients (mean age-adjusted score was 32.7 versus
18.4 overall, 34.8 versus 18.0 in SBP patients, and 32.0 versus
18.5 in non-SBP patients; all P<0.001). Furthermore, the
mean MELD score was signiﬁcantly diﬀerent in patients whoGastroenterology Research and Practice 3
Table 1: Association of selected risk factors with spontaneous bacterial peritonitis (SBP) in hepatic cirrhosis patients with ascites.
Variable Without SBP (N = 192) With SBP (N = 64) P value
Age (years) 54.56 (52.73–56.38)∗ 54.20 (51.04–57.36)∗ 0.849
MELD score 19.49 (18.38–20.60) 23.20 (21.27–25.12) 0.001
MELD group 0.046‡
≤15 64 (33.3)† 12 (18.8)† —
16–24 81 (42.2) 28 (43.8) 0.111
≥25 47 (24.5) 24 (37.5) 0.013
Bilirubin (mg/dL) 5.41 (4.38–6.44) 6.34 (4.56–8.13) 0.373
Creatinine (mg/dL) 0.99 (0.92–1.06) 1.08 (0.96–1.20) 0.229
INR (units) 2.57 (2.24–2.90) 2.27 (1.70–2.84) 0.364
Sex
Women 41 (21.4) 16 (25.0) 0.887‡
Men 151 (78.6) 48 (75.0)
Etiology
Alcohol 100 (52.1) 36 (56.3) 0.111‡
Other§ 92 (47.9) 28 (43.7)
Diabetes
No 139 (72.4) 44 (68.7) 0.560‡
Yes 53 (27.6) 20 (31.3)
Death
No 169 (88.0) 49 (76.6) 0.024‡
Yes 23 (12.0) 15 (23.4)
∗Mean age-adjusted values and 95% conﬁdence intervals (in parenthesis) from the general linear model.
†Number and column percentages (in parenthesis).
‡Age-adjusted P values from binary logistic regression.
§HBV, HCV, or alcohol + virus.
died in the group of SBP compared to those who died in the
group without SBP (P = 0.01).
4. Discussion
Our transversal study evaluated the relationship between the
MELD score and the development of SBP in the consecutive
patients with cirrhosis and ascitis. We found that a higher
MELD score was independently associated with a higher risk
ofSBP.Also,weconcludedthatMELDscorewasasigniﬁcant
predictor of hospital mortality in patients with SBP.
The prevalence of SBP as a complication of the ascitic
cirrhotic patients included in our study was 25%. It was not
much diﬀerent from the other studies conducted in USA
and the European countries [9, 10, 21]. This may be due
to relatively high percentage of alcoholic cirrhosis in our
country, which is more disposed to develop SBP. Lata et al.
reported that the prevalence of SBP is higher in the cirrhosis
patients whose ascites is caused by alcohol consumption
rather than by viral hepatitis [9], whereas Kaymakoglu et al.
came to the opposite conclusion [21]. In the present study,
SBP is more frequent in alcoholic-related cirrhosis patients.
A main ﬁnding was the strong and statistically signiﬁcant
association of MELD score with SBP, indicating that MELD
score may be a useful tool to predict the development of
SBP. The patients with moderate to high MELD scores have
a substantially greater risk of SBP. The other studies reported
the same results; in the study of Malinchoc et al. the mean
MELD score of 19.1 in patients with ascites without SPB is
lower than the mean MELD score (24.8) of patients with SBP
[22], while Gayatri et al. conducted that severe liver cirrhosis
with MELD score ≥18 was associated with an increase risk of
SBP[23].LivercirrhosiswithhighMELDscoresisassociated
with increased intestinal permeability, which increases the
risk for bacterial translocation. Moreover, immunological
clearance is decreased in advanced cirrhosis [24]. Therefore,
SBP occurs more frequently in patients with advanced
cirrhosis.
The MELD score has a predictive value in hospital mor-
tality in patients with end-stage liver disease of diverse
etiologies and severity [17, 18]. This prognostic ability of
MELD is also conﬁrmed in our study. However, there are few
published data, about predictive ability of MELD in hospital
mortality in SBP [25]. Our ﬁnding that MELD score is an
independent predictor of hospital mortality in SBP is in the
same line with results of the study of Nobre et al. [25].
ThefactthatwefoundalsohigherlevelofMELDscorein
patients with fatal outcome reﬂects its predictive value based
upon biochemistry ﬁndings, which combined in this way
clearly show the gravity of cirrhotic liver disease. If we take
intoconsiderationthevaluesofINR,creatinineandbilirubin
separately, we do not ﬁnd the same statistical predictive
signiﬁcance.
Presence of SBP may be also considered an important
sign of deterioration of the liver disease with more frequent4 Gastroenterology Research and Practice
fatal outcome, as seen in our cohort of patients, due to their
disposal to develop hepatorenal syndrome. The renal failure,
d u et of u r t h e rr e d u c t i o no fe ﬀective circulating volume, is
still a common cause of death in the patients with SBP [26].
The serum creatinine has been shown to have a deter-
minant impact on the prognosis of cirrhosis [27]. This
parameter is not included in the Child-Turcotte-Pugh score.
On the other hand, the MELD score has other advantages
when compared with the Child-Pugh score. First, it uses
objective parameters second, its objective parameters are less
subject to center-to-center variability such as the Child clas-
siﬁcation, and, third, the MELD score increases as the three
constituent parameters deteriorate, whereas the individual
scoring elements in the Child score remain ﬁxed once a
deﬁned threshold has been reached [28].
Our study may have several limitations. We assessed
potentialconfounderssuchasage,sex,diabetes,andetiologic
factors of cirrhosis, none of which substantially altered the
relationship between MELD score and SBP. However, it
remains possible that some unrecognized potential con-
founders may in fact exist and could have inﬂuenced the
results. Furthermore, the diagnostic paracentesis in all pa-
tients was performed upon hospital admission and no infor-
mation was available with regard to the time elapsed since
the onset of SBP. Also, we excluded from the study the
patientswhowerereceivingPPIbecausetheacid-suppressive
therapymayleadtosmallintestinalbacterialovergrowthand
subsequent bacterial translocation into the peritoneal cavity
and ﬁnally increase the risk of SBP [29].
The clinical spectrum of SBP is quite variable, ranging
from sings of peritonitis to complete absence of symptoms;
therefore the diagnosis relies on the high index of suspicions
and the examination of the ascitic ﬂuid [30]. Our study
supportsthefactthatMELDscorehasahighpredictivevalue
for the SBP development and fatal outcome in liver cirrhosis.
TheseﬁndingscanbeusefulforincreasingsuspicionsforSBP
development in hospitalized cirrhotic patients with elevated
MELD score.
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